EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
191.15%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - P/B ratio
P/B ratio as of May 2024 : 3.90
According to EyePoint Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 3.90.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
EyePoint Pharmaceuticals - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.24 | 242.36% |
| 2022-12-31 | 1.24 | -44.99% |
| 2021-12-31 | 2.25 | -58.09% |
| 2020-12-31 | 5.37 | -73.63% |
| 2019-12-31 | 20.4 | 438.83% |
| 2018-12-31 | 3.78 | -23.43% |
| 2017-12-31 | 4.93 | 24.64% |
| 2016-12-31 | 3.96 | -60.01% |
| 2015-12-31 | 9.90 | 164.34% |
| 2014-12-31 | 3.75 | -56.46% |
| 2013-12-31 | 8.60 | 321.41% |
| 2012-12-31 | 2.04 | 57.29% |
| 2011-12-31 | 1.30 | -57.37% |
| 2010-12-31 | 3.04 | 3.47% |
| 2009-12-31 | 2.94 | 273.48% |
| 2008-12-31 | 0.7878 | 12823.68% |
| 2007-12-31 | 0.0061 | -48.23% |
| 2006-12-31 | 0.0118 | -99.66% |
| 2005-12-31 | 3.45 | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -262.69% | Bahamas |
 NRC Health
NRC | 17.1 | 337.28% | 🇺🇸 USA |